Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
08/2000
08/17/2000WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047207A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047201A1 The pharmacological use of certain cystine derivatives
08/17/2000WO2000009109A3 Pipecolic acid derivatives for vision and memory disorders
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362392A1 Heterocyclic derivatives as inhibitors of factor xa
08/17/2000CA2362375A1 Alkenyl and alkynyl compounds as inhibitors of factor xa
08/17/2000CA2361919A1 Lactam inhibitors of fxa and method
08/17/2000CA2361428A1 Inhibitors of factor xa
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360305A1 Lactam inhibitors of fxa and method
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027333A1 Thrombin inhibitors
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027051A1 Antithrombotic agents
08/16/2000EP1027036A2 Taste masked formulations
08/16/2000EP0726076B1 Method of stabilizing protein c or activated protein c and stabilized composition
08/16/2000EP0509080B1 Inhibitors and substrates of thrombin
08/16/2000CN1263556A Anti-GPIIB/IIIA recombinant antibodies
08/16/2000CN1263533A New formulation
08/16/2000CN1262955A Chinese medicine powder preparation for curing leukemia
08/16/2000CN1055411C Implantation under skin type traditional Chinese patent styptic medicine
08/16/2000CN1055407C Method for preparing Chinese medicine for curing and preventing apoplexy
08/16/2000CN1055405C Capsule for curing thromboangitis
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103740 Methods for lowering platelet counts
08/15/2000US6103738 Quinoline and quinazoline compounds useful in therapy
08/15/2000US6103705 Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
08/15/2000US6103693 Method for isolation of highly pure von willebrand factor
08/15/2000US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy
08/15/2000US6103499 Inhibitors of human plasmin derived from the Kunitz domains
08/15/2000US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof
08/15/2000CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid
08/15/2000CA2046883C Heterocyclic derivatives, method for preparing same, and their therapeutic applications
08/10/2000WO2000046349A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046228A2 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000WO2000046227A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/10/2000WO2000046225A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000WO2000046224A2 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046214A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
08/10/2000WO2000046208A1 Substituted pyrazole carboxylic acids used to combat anaemias
08/10/2000WO2000046207A1 Pyrazole alkylamides
08/10/2000WO2000046206A1 Substituted pyrazole benzyl amine derivatives to combat anaemias
08/10/2000WO2000045894A2 Use of pyrazole carboxamides
08/10/2000WO2000045873A1 Methods and compositions for use in perfusion applications
08/10/2000WO2000045837A1 Novel use within transplantation surgery
08/10/2000WO2000045814A1 Methods and compositions to enhance white blood cell count
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000027822A3 Tricyclic pyrazole derivatives
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000DE19904406A1 Substituierte Pyrazolcarbonsäuren Substituted pyrazole
08/10/2000DE19904397A1 Verwendung von Pyrazol-Carbonsäureamiden Use of pyrazole carboxamides
08/10/2000DE19904396A1 Substituierte Pyrazolbenzylamin-Derivate Pyrazolbenzylamin substituted derivatives
08/10/2000DE19904391A1 Pyrazol-Alkylamide Pyrazole-alkylamides
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361816A1 Substituted pyrazole carboxylic acids used to combat anaemias
08/10/2000CA2361636A1 Use of pyrazole carboxamides
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2358895A1 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000CA2358894A1 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000CA2358892A1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000CA2358891A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/09/2000EP1026250A1 DNA-constructs of blood clotting factors and P-selectin
08/09/2000EP1025086A1 Benzamidine derivatives as factor xa inhibitors
08/09/2000EP1025083A1 Process for stereoselective synthesis of prostacyclin derivatives
08/09/2000EP1024831A2 Application of tnf antagonists as medicaments for treating septic diseases
08/09/2000EP1024789A1 Solution for peritoneal dialysis and process for its manufacture
08/09/2000EP0789777B1 Polysaccharides having a high iduronic acid content
08/09/2000CN1262690A Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of same
08/09/2000CN1262688A Integrin binding peptide and use thereof
08/09/2000CN1055214C Method for producing Chinese medicinal liquor for curing acquired scar and product thereof
08/09/2000CN1055212C Traditional Chinese medicine preparation for coagulating blood
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100236 Method and composition for treating thrombosis
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099854 Dry composition containing flavonol useful as a food supplement
08/08/2000US6099837 Pharmaceutical preparation for treating blood coagulation disorders
08/08/2000US6099823 Compositions and methods for the treatment and diagnosis of cardiovascular disease
08/08/2000CA2185019C Isoxazoline compounds as inhibitors of tnf release
08/08/2000CA1341073C Vectors and methods for expression of human protein c activity
08/03/2000WO2000044777A1 Antibodies specific to kdr and uses thereof
08/03/2000WO2000044753A1 Pirazino(aza)indole derivatives
08/03/2000WO2000044749A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044714A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044398A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000WO2000044366A2 Therapeutic compositions containing glutathione analogs
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
1 ... 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 ... 671